---
layout: page
title: ""
description: The pages meta description
hero_image: /img/Ailith_research_image_withname.jpg
hero_height: is-small
---

# Publications

## Recent highlights

<br>

<div class="row">
    <div class="columns">
        <div class="column">
            <img src="/img/Fig1_markerHGSOC.png" alt="Landscape of HGSOC" width="1000"/>
            </div>
            <div class="column">
                <br>
                <br>    
                <br>
                <p><b>Divergent trajectories to structural diversity impact patient survival in high grade
serous ovarian cancer.</b></p>
                <p><a href="https://www.biorxiv.org/content/10.1101/2024.01.12.575376v1.full.pdf"> Ewing et al (2024), bioRxiv.</a></p>
                <p> Contributions from <b>Jo</b>, <b>Kitty</b> and <b>Stuart</b>.</p>

        </div>
    </div>
</div>

## Selected publications

Hamdan A and <b>Ewing A</b>. 'Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis'. (2022) The Journal of Pathology, https://doi.org/10.1002/path.5901.

Gershenson D, Miller A, Brady WE, ..., <b>Ewing A</b>,..., Gourley C. 'Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial'. (2022) The Lancet. (399) (10324) 541-553.

<b>Ewing A</b>, Meynert A, Churchman M et al. 'Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma' (2021) Clinical Cancer Research (27) (11) 3201-3214.

Aitken SJ, Anderson CJ, Connor F, …,<b>Ewing A</b>,…, Taylor M. ‘Pervasive lesion segregation shapes cancer genome evolution’ (2020) Nature 583 (7815), 265-270.

Travnickova J, Wojciechowska S, Khamseh A,…<b>Ewing A</b>…Patton E. ‘Zebrafish MITF-low melanoma subtype models reveal transcriptional subclusters and MITF-independent residual disease’ (2019). Cancer research. 79 (22), 5769-5784.

<b>Ewing A</b>, Semple C. ‘Breaking point: the genesis and impact of structural variation in tumours’ (2018) F1000Research 7.

Phelan CM, Kuchenbaecker KB, JP Tyrer,… <b>Pirie A</b> … Pharoah PDP. ‘Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer’ (2017) Nature genetics 49 (5), 680-691.

Permuth JB\*, <b>Pirie A\*</b>, Chen A et al. ‘Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.’ (2016) Human Molecular Genetics 25 (16), 3600-3612. (* - equal contributions).

Winham S\*, <b>Pirie A\*</b>, Chen A et al. ‘Investigation of exomic variants associated with overall survival in ovarian cancer’ (2016) Cancer Epidemiology Biomarkers and Prevention. Mar;25(3):446-54. (* - equal contributions)

<b>Pirie A</b>, Guo Q, Kraft P et al. ‘Common germline polymorphisms associated with breast cancer specific survival’ (2015) Breast Cancer Research. 17:58.

<b>Pirie A</b>, Wood A, Lush M et al. ‘The effect of rare variants on inflation of the test statistics in case-control analyses’ (2015) BMC Bioinformatics 16:53.

<br>
<p align="center">
Full list of publications on <a href="https://scholar.google.com/citations?user=fyFBEi8AAAAJ&hl=en">Google Scholar</a>
</p>

